Kidney Res Clin Pract.
2021 Sep;40(3):329-331. 10.23876/j.krcp.21.000.
A novel role of copeptin as a biomarker for the prediction of treatment response in hyponatremia
- Affiliations
-
- 1Department of Internal Medicine, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Republic of Korea
- KMID: 2524378
- DOI: http://doi.org/10.23876/j.krcp.21.000
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Serum copeptin as a predictor of risk of hyponatremia after transurethral prostatectomy
- Association between copeptin levels and treatment responses to hypertonic saline infusion in patients with symptomatic hyponatremia: a prospective cohort study
- Preoperative Serum Copeptin Can Predict Delayed Hyponatremia after Pituitary Surgery in the Absence of Arginine Vasopressin Deficiency
- Copeptin in Hemodialysis Patients with Left Ventricular Dysfunction
- Pathophysiology of copeptin in kidney disease and hypertension
